WVE
Wave Life Sciences Ltd
NASDAQ: WVE · HEALTHCARE · BIOTECHNOLOGY
$7.06
+0.14% today
Updated 2026-04-30
Market cap
$1.36B
P/E ratio
—
P/S ratio
18.89x
EPS (TTM)
$-1.05
Dividend yield
—
52W range
$5 – $22
Volume
4.6M
Wave Life Sciences Ltd (WVE) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.55M | $-4.43M | $-12.53M | $-31.87M | $-83.67M | $-22.86M | $-188.23M | $-115.98M | $-88.99M | $-127.78M | $-19.43M | $-151.03M | $-187.49M |
| Capital expenditures | $47000.00 | $590000.00 | $1.86M | $5.57M | $18.89M | $9.94M | $3.92M | $1.34M | $560000.00 | $1.36M | $1.11M | $938000.00 | $718000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $14000.00 | $4.02M | $6.85M | $12.14M | $15.60M | $19.51M | $14.30M | $16.41M | $17.19M | $9.79M | $13.14M | $24.97M |
| Free cash flow | $-3.60M | $-5.02M | $-14.38M | $-37.44M | $-102.56M | $-32.80M | $-192.15M | $-117.32M | $-89.55M | $-129.14M | $-20.55M | $-151.96M | $-188.21M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $113.08M | $30.00M | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $160.17M | $-10.93M | $-7.79M | $32.29M | — | $37.22M | $-33.73M | $-61.85M | — | — | — |